Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Choriocarcinoma × Reoperation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1 Choriocarcinoma 1 Carcinoma, Embryonal 1

Interventions

carotuximab 2 Bevacizumab 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 Thiotepa 1 Specimen Handling 1 Second-Look Surgery 1 Reoperation 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Drug Therapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04684368 2026-02-24

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡